Jessica A Marathe
Overview
Explore the profile of Jessica A Marathe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dang Q, Psaltis P, Burgess S, Chandrasekhar J, Mukherjee S, Kritharides L, et al.
Eur Heart J
. 2025 Mar;
PMID: 40049585
Background And Aims: Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndrome (ACS). Recent data suggest a harmful association of dual antiplatelet therapy compared with...
2.
Girolamo O, Tavella R, Di Fiore D, Sheikh A, Pasupathy S, Ooi E, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004885
: The diagnosis of coronary artery spasm (CAS) frequently requires invasive provocation testing, typically utilising acetylcholine (ACh). Although the left coronary artery (LCA) is routinely assessed as a part of...
3.
Le R, Nguyen M, Allahwala M, Psaltis J, Marathe C, Marathe J, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200816
Owing to their potent glucose-lowering efficacy and substantial weight loss effects, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now considered part of the frontline therapeutic options to treat both type...
4.
Psaltis P, Nguyen M, Singh K, Sinhal A, Wong D, Alcock R, et al.
Cardiovasc Res
. 2024 Aug;
PMID: 39189611
Background: Low-dose colchicine reduces the risk of cardiovascular events after myocardial infarction (MI). The purpose of this study was to assess the effect of colchicine post-MI on coronary plaque morphology...
5.
Psaltis J, Marathe J, Nguyen M, Le R, Bursill C, Marathe C, et al.
Med Res Rev
. 2024 Aug;
45(1):29-65.
PMID: 39139038
Among newer classes of drugs for type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are incretin-based agents that lower both blood sugar levels and promote weight...
6.
Franke K, Montarello N, Nelson A, Marathe J, Wong D, Tavella R, et al.
Int J Cardiol Heart Vasc
. 2024 May;
52:101417.
PMID: 38725440
Background: Although the clinical factors associated with progression of coronary artery disease have been well studied, the angiographic predictors are less defined. Objectives: Our objective was to study the clinical...
7.
Ovadia C, Sajous J, Seed P, Patel K, Williamson N, Attilakos G, et al.
Lancet Gastroenterol Hepatol
. 2021 Apr;
6(7):547-558.
PMID: 33915090
Background: Ursodeoxycholic acid is commonly used to treat intrahepatic cholestasis of pregnancy, yet its largest trial detected minimal benefit for a composite outcome (stillbirth, preterm birth, and neonatal unit admission)....
8.
Marathe C, Pham H, Marathe J, Trahair L, Huynh L, Wu T, et al.
Acta Diabetol
. 2019 Dec;
57(5):583-587.
PMID: 31848710
Aims: Glucose-dependent insulinotropic polypeptide (GIP) is released primarily from the proximal small intestine and glucagon-like peptide-1 (GLP-1) from the more distal small intestine and colon. Their relative importance to the...
9.
Marathe C, Marathe J, Rayner C, Kar P, Jones K, Horowitz M
Diabetes Obes Metab
. 2018 Nov;
21(3):491-498.
PMID: 30378748
Hypoglycaemia is arguably the most important complication of insulin therapy in type 1 and type 2 diabetes. Counter-regulation of hypoglycaemia is dependent on autonomic function and frequent hypoglycaemia may lead...
10.
Marathe J, Lim W, Metz M, Scheil W, Dekker G, Hague W
Eur J Obstet Gynecol Reprod Biol
. 2017 Sep;
218:33-38.
PMID: 28926728
Objective: To review the management and outcomes of Intrahepatic Cholestasis of Pregnancy (ICP) in South Australia (SA) over the past decade. Design: Retrospective cohort review. Setting: Public clinics at two...